Latest Remuneration News

Page 15 of 120
Provaris Energy reported a $4.045 million loss for FY2026 as it progressed proprietary hydrogen and liquid CO₂ storage technologies, expanded strategic partnerships, and boosted cash reserves through multiple placements.
Maxwell Dee
Maxwell Dee
28 Aug 2026
PYC Therapeutics strengthened its financial footing with a $600 million capital raise and made notable clinical progress across four RNA therapeutic programs targeting genetic diseases.
Ada Torres
Ada Torres
28 Aug 2026
Queste Communications Ltd (ASX:QUE) posted a 66% increase in company-level profit for FY2026, but its consolidated entity, including Orion Equities (ASX:OEQ), saw earnings decline sharply amid weaker revenues and investment losses. No dividend was declared.
Claire Turing
Claire Turing
28 Aug 2026
Orion Equities (ASX:OEQ) returned to profitability in FY26 with a $204,000 net profit, buoyed by a $400,000 uplift in investment property value. Despite a 7% dip in total revenue, net tangible asset backing per share edged up to $0.43, while no dividend was declared.
Claire Turing
Claire Turing
28 Aug 2026
Tartana Minerals has lodged a cleansing prospectus to enable ASX quotation of over 129 million options linked to a $4.5 million placement, with exercise price set at 5.5 cents and expiry in April 2029.
Maxwell Dee
Maxwell Dee
28 Aug 2026
Moonlight Resources Ltd (ASX: ML8) completed its first year as a listed entity, rapidly expanding its gold and copper exploration at the Clermont Project in Queensland. The company reported a net loss of $1.98 million for FY2026, reflecting active exploration and corporate growth following its December 2025 IPO.
Maxwell Dee
Maxwell Dee
28 Aug 2026
SIV Capital posted a 244% increase in net loss for FY26 to $388,049 on a 33% revenue drop, with its legacy rental business winding down and ASX suspension ongoing. The company is pursuing a new transaction to regain listing approval.
Claire Turing
Claire Turing
28 Aug 2026
Paradigm Biopharmaceuticals has surpassed its Phase 3 enrolment target for Zilosul®, secured over A$21 million in capital, and pivots towards clinical evidence generation with major data readouts expected.
Ada Torres
Ada Torres
28 Aug 2026
SPC Global reported a 27% rise in normalised EBITDA for FY26 to $38.5 million, supported by a $100 million equity raise that halved net leverage. The company’s strategic pivot to higher-margin branded products and operational efficiencies set the stage for targeted double-digit revenue and EBITDA growth in FY27.
Victor Sage
Victor Sage
28 Aug 2026
WAM Alternative Assets nearly doubled its pre-tax profit in FY2026, driven by a 9.1% portfolio gain and a decisive shareholder vote backing its strategy. The company declared a 6.0 cents per share dividend, partially franked at 60%, reflecting portfolio maturation and diversification.
Claire Turing
Claire Turing
28 Aug 2026
Critical Minerals Group names COO Pat Kelly as interim CEO following Scott Winter's resignation to lead BTP. The company confirms its strategy and Lindfield Vanadium Project plans remain steady during the transition.
Maxwell Dee
Maxwell Dee
28 Aug 2026
Farm Pride Foods Ltd reported a 16% revenue increase to $118.3 million and a 53% jump in net profit to $10.2 million for FY26, underpinned by operational improvements and strategic capital investments.
Victor Sage
Victor Sage
28 Aug 2026

Browse the archive

Full archive